Product Finder

Select by:

View all products
View all news

Other Products from this Line

Toflux Jarabe

Granules x 200 mg: containers with 20 packs. Granules x 600 mg: containers with 10 and 20 packs.

Syrup: granules to prepare 100 ml.


View more

Montrate

Coated tablets: Packs containing 30 coated tablets. Chewing tablets: Packs containing 30 coated tablets.


View more

Vacuna Oral Casasco

Packages containing 20 tablets. Droplets provider bottles of 30 ml.


View more

Inhalan Plus

Bottles containing 60 doses.


View more

Product Line:

Respiratory Line

Patient Product Information

Formulation:
7 mg capsules: each capsule for Adults contains: Standardized Lyophilized Bacterial Lysates (*) 40.000 mg; Excipients  q.s; (*): 40 mg composition of Standardized Lyophilized: Lyophilized Bacterial Lysates of: Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis 7.000 mg; Excipients  q.s; 3.5 mg capsules: each capsule for Children contains: Standardized Lyophilized Bacterial Lysates (*) 20.000 mg; Excipients  q.s; (*): 20 mg composition of Standardized Lyophilized: Lyophilized Bacterial Lysates of: Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis 3.500 mg; Excipients  q.s

Therapeutical Action:
immunostimulant agent.

Indications:
immunotherapy.Prevention of respiratory airways recurrent infections and acute infectious exacerbations of chronic bronchitis.
Adjunctive treatment of respiratory airway acute infection.

Dosage and Administration
Preventive treatment and/ or consolidation therapeutics: a daily capsule administered under fasting conditions during 10 consecutive days in a month during a total period of 3 months.
Treatment of acute episodes: a daily capsule administered under fasting conditions until the symptoms disappear (at least 10 days). When the treatment requires antibiotics simultaneous administration, the combination with BRONCHO-VAXOM is recommended from the beginning of the therapeutics.
Children from 6 months to 12 years old: The same use as for adults since BRONCHO-VAXOM “children” represents half dose of BRONCHO-VAXOM “adults”.
Note: BRONCHO-VAXOM “children” capsules may be opened and its content may be poured in a drink (fruit juice, milk, etc.) in cases in which the child has difficulties in swallowing.

Contraindications:
known hypersensitivity to BRONCHO-VAXOM components.

How-Supplied:
Adults: packages containing 10 and 30 capsules. Children: packages containing 10 and 30 capsules.